News | July 22, 2023
Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin
Good momentum in commercial CDMO business
Good momentum in commercial CDMO business
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
The company will submit its comprehensive response on these observations to the USFDA
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
The inspection closed with zero observations
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
